Drug-drug Interaction Study Between UIC201603, and UIC201604

Phase 1 Completed 57 enrolled Korea United Pharm. Inc.

RandomizedSequentialOpen-labelOther

Summary

An open-label, multiple-dosing, two-arms, one-sequence study to evaluate the safety and pharmacokinetics after co-administration of UIC201603 and UIC201604 in healthy volunteers

Timeline

Start: 2017-03-15
Primary completion: 2017-07-04
Completion: 2018-02-07

Publications

Kim DH, Hong JH, Jung WT, Nam KY, Roh JS, Lee HJ, Moon J, Kim KY, Jung JG, Sunwoo J. Pharmacokinetic Drug-Drug Interaction between Cilostazol and Rosuvastatin in Healthy Participants. Am J Cardiovasc Drugs. 2025 Mar;25(2):267-276. doi: 10.1007/s40256-024-00686-w. Epub 2024 Nov 2.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Cilostazol	Small molecule	200 mg	—
Subject	Rosuvastatin	Small molecule	20 mg	—

Indications

No indication recorded.